Skip to main content

2025 Investiture Information

All Thayer News

Antibody Startup Adagio Raises $336 Million To Develop A Variant-Proof Treatment For COVID-19

Apr 19, 2021   |   Forbes

Link to source:

https://www.forbes.com/sites/leahrosenbaum/2021/04/19/antibody-startup-adagio-raises-336-million-to-develop-a-variant-proof-treatment-for-covid-19/?sh=315e515076b0

For contacts and other media information visit our Media Resources page.